AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Hour Loop, Inc.
Video analysis: HOUR
All videosNo video analysis for this stock yet. Request one from our team.
News: HOUR
48-HOUR REGN INVESTOR DEADLINE: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
San Diego, California--(Newsfile Corp. - September 12, 2026) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) common stock between August 1, 2025 and May 15, 2026, inclusive (the "Class Period"), have until this upcoming Monday, September 14, 2026 to seek appointment as lead plaintiff of the Regeneron class action lawsuit. Captioned Cheatham v.
Hour Loop's Q2 Earnings Fall Year Over Year on Margin Pressure
HOUR's Q2 earnings per share decrease year over year on lower gross margins, while revenues climb 25%. Management maintains its full-year 2026 guidance.
Hour Loop Reports Second Quarter of 2026 Results
Continued Profitability Despite a Challenging Economic Environment Redmond, WA, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Hour Loop, Inc. (NASDAQ: HOUR) (“Hour Loop” or the “Company”), a leading online retailer, announces its financial and operational results for the quarter ended June 30, 2026 Financial Highlights for Second Quarter of 2026: Net revenues increased 25% to $33.9 million, compared to $27.1 million in the year-ago period; Net income decreased to $1.1 million, compared to $1.2 million in the year-ago period; and Cash used in operating activities was $3.6 million, compared to cash used in operating activities of $0.9 million in the year-ago period. Management Commentary “This was a remarkable quarter for Hour Loop.
